Financial Support for Heart Failure
(FUND-HF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a one-time $500 payment can help people with heart failure take their medications more effectively and improve their quality of life. It targets individuals with heart failure with reduced ejection fraction (a measure of heart pumping efficiency) who face financial difficulties. Participants will be divided into two groups: one receives the payment upfront, and the other after a month. The trial will compare these groups in terms of medication adherence and quality of life. It is suitable for those who struggle to pay bills, earn less than the federal poverty limit, and face social challenges like food insecurity or housing instability. As an unphased trial, this study provides a unique opportunity to explore innovative support strategies for enhancing health and quality of life.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. It focuses on financial support to improve medication adherence, so it's likely you will continue your current medications.
What prior data suggests that financial support is safe for heart failure patients?
Research has shown that financial support can improve health. Programs like SNAP (Supplemental Nutrition Assistance Program) have been linked to better health in people with heart disease and other conditions. This suggests that financial help might reduce stress and enhance overall well-being.
In the trial under consideration, participants will receive a one-time $500 payment to determine if it helps them take their medication regularly and improves their quality of life. Since this trial involves financial support rather than medication or medical procedures, there are no direct safety concerns such as side effects. The main goal is to discover if extra money can help people adhere to their medication plans and feel better overall.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential impact of financial support as a unique approach to managing heart failure. Unlike traditional treatments that focus on medications like beta-blockers, ACE inhibitors, or lifestyle changes, this trial examines whether providing financial assistance can improve patient outcomes. The immediate financial support group receives $500 right after their baseline visit, while the delayed group gets the same amount one month later. This innovative angle could reveal how easing financial stress might directly influence health, offering a new dimension to heart failure care.
What evidence suggests that financial support could improve quality of life and medication adherence for heart failure patients?
This trial will compare Immediate Financial Support with Delayed Financial Support for participants. Research has shown that financial help, such as the Supplemental Nutrition Assistance Program (SNAP), links to better health and lower healthcare costs. Adequate food access is crucial for heart health. Studies have found that healthier food options connect to fewer deaths from heart failure. Financial assistance can improve food access, which helps reduce heart risks. Overall, financial support may enhance quality of life and help individuals maintain their medications by alleviating financial stress.26789
Who Is on the Research Team?
Ambarish Pandey, MD
Principal Investigator
UT Southwestern Medical Center
Are You a Good Fit for This Trial?
This trial is for adults over 18 with heart failure and reduced ejection fraction, living on a low income (below 130% of the Federal Poverty Limit), who have trouble paying bills and at least two other social challenges like food or housing issues. They must be English-speaking, from Dallas County, not in jail/prison, able to see well enough to participate, and willing to return for follow-up visits.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Visit
Participants complete surveys on quality of life, social stress, and spending habits. Random assignment to receive $500 or $0.
1-Month Follow-up
Quality of life and medication adherence are assessed. Participants in the delayed financial support group receive $500.
2-Month Follow-up
Quality of life and medication adherence are assessed for the delayed financial support group.
Follow-up
Participants are monitored for safety and effectiveness after the intervention period.
What Are the Treatments Tested in This Trial?
Interventions
- Financial Support
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor